Back to Search
Start Over
Tadalafil and modifications in peak systolic velocity (Doppler spectrum dynamic analysis) in the cavernosal arteries of patients with type 2 diabetes after continuous tadalafil treatment.
- Source :
-
Minerva endocrinologica [Minerva Endocrinol] 2006 Dec; Vol. 31 (4), pp. 251-61. - Publication Year :
- 2006
-
Abstract
- Aim: In this study peak systolic velocity (PSV) was measured by penile duplex Doppler spectrum dynamic analysis in diabetic patients with erectile dysfunction (ED) administered continuous treatment with tadalafil for 3 months in a weekly regimen (Monday-Wednesday-Friday). Responses to the Structured Interview on Erectile Dysfunction (SIEDY) questionnaire and hormonal blood levels (LH, testosterone, prolactin) were studied before and after treatment.<br />Methods: The study sample was 20 diabetic patients (mean age 60 years; range 55-65) with organic vascular arterial ED at enrollment into the study. All patients were eligible for receiving tadalafil. Patients were randomly assigned to 2 different treatment groups according to a computer-generated list. The first random set of numbers was assigned to group A, the second to group B. Group A (n=10) received tadalafil 20 mg per os on demand for 3 months (Cialis, Lilly ICOS; London, UK). Group B (n=10) received tadalafil 20 mg per os on weekly fixed days (Monday-Wednesday-Friday) for 3 months. All patients underwent duplex penile sonographic dynamic evaluation after intracavernosal injection of alprostadil 20 microg (Caverject, Pharmacia SpA; Milan, Italy); SIEDY questionnaire responses and changes in blood hormonal levels (LH, testosterone, prolactin) before and after treatment were compared.<br />Results: Increased PSV at 10 min and 20 min after alprostadil administration was found in 30% of Group A patients and in 60% of Group B patients. In 40% of Group B patients, the increase in PSV was so significant as to justify reclassification to a less severe diagnostic category (Benson classification) in vascular profile. No changes in hormonal levels after treatment were found in either group. Analysis of the questionnaires showed a more marked reduction in the global total scores in Group B, with a greater frequency and a clearer improvement in global scores.<br />Conclusions: This study on a group of 20 patients with organic vascular arterial ED disclosed at least 2 basic aspects: 1) a higher percentage of Group B patients (fixed-day treatment regimen) showed a greater improvement in PSV than the controls; 40% of these patients were reclassified according to the Benson classification; 2) within the context of a clinical study, monitoring and supportive care to increase the frequency and quality of sexual intercourse led to a resumption of and a greater interest in sexual activity. This finding cannot be explained by changes in hormonal levels; instead, there appeared a sort of effect placebo that the continuous therapy, like conventional treatment for other health reasons, had on the patient.
- Subjects :
- Aged
Alprostadil administration & dosage
Arteries drug effects
Arteries physiopathology
Attitude to Health
Carbolines administration & dosage
Drug Administration Schedule
Erectile Dysfunction blood
Erectile Dysfunction etiology
Erectile Dysfunction psychology
Humans
Injections
Luteinizing Hormone blood
Male
Middle Aged
Nitric Oxide metabolism
Prolactin blood
Surveys and Questionnaires
Tadalafil
Testosterone blood
Treatment Outcome
Vasodilator Agents administration & dosage
Blood Flow Velocity drug effects
Carbolines therapeutic use
Diabetes Mellitus, Type 2 complications
Diabetic Angiopathies complications
Erectile Dysfunction drug therapy
Penis blood supply
Vasodilator Agents therapeutic use
Subjects
Details
- Language :
- English; Italian
- ISSN :
- 0391-1977
- Volume :
- 31
- Issue :
- 4
- Database :
- MEDLINE
- Journal :
- Minerva endocrinologica
- Publication Type :
- Academic Journal
- Accession number :
- 17213792